Does removing a blood vessel help in hilar bile duct cancer surgery?
Part of Cancer clinical trials.
This study looks at patients who had surgery for a specific type of bile duct cancer (hilar cholangiocarcinoma). It aims to see whether removing a nearby blood vessel during that surgery helps people live longer and have fewer complications after the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for a type of bile duct cancer called hilar cholangiocarcinoma, which is located at the liver's exit point.
- Your tumor was confirmed to be this type of cancer by a biopsy or after surgery.
- Your surgical team either removed a nearby blood vessel during the surgery or did not need to.
- Your cancer had not spread to distant organs before or during the surgery.
- You have complete medical records and follow-up information from your treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a surgery that removes part of the liver and bile ducts in a specific way for bile duct cancer at the liver hilum. The goal is to see if this approach helps improve survival and quality of life.
This study looks for links between Helicobacter bacteria and cancers of the bile ducts and gallbladder. It compares patients with bile duct cancer, people having gallbladder surgery for non-cancer reasons, and healthy liver donors.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This trial tests a treatment plan for people with bile duct cancer that has invaded the main liver artery, making surgery difficult. The treatment is given before surgery to shrink the tumor and improve the chances of successful removal.
This study looks at whether removing more lymph nodes while surgically removing an intrahepatic cholangiocarcinoma (bile duct cancer in the liver) improves outcomes. It may help by better checking and treating possible microscopic spread to lymph nodes.
Hear when a new Cholangiocarcinoma, Hilar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.